U.S. Alzheimer's Disease Medication Market

U.S. Alzheimer's Disease Medication Market

 

RELEASE DATE
04-Aug-2010
REGION
North America
Research Code: N731-01-00-00-00
SKU: HC02145-NA-MR_07723
AvailableYesPDF Download

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC02145-NA-MR_07723

$4,950.00

$3,712.50save 25 %

DownloadLink
ENQUIRE NOW

Description

This research service provides an indepth analysis of factors affecting the growth of the U.S. Alzheimer's disease medication market over the period 2006-2016. Following an introduction to the market, which includes segmentation, patient forecasts, and market trends, readers are presented with a detailed examination of therapeutic candidates in Alzheimer's pipeline. Finally, revenue forecasts and market share analyses are presented for existing therapies as well as three new-mechanism drugs with potential to reach the market within the forecast period.

Table of Contents

U.S. Alzheimer's Disease Medication Market

  • Introduction

Research Scope and Methodology

  • Scope and Segmentation
  • Research Methodology
  • Information Update Regarding Eli Lilly’s Discontinuation of semagacestat Clinical Trials

Disease Overview and Patient Forecasts

  • Disease Overview
  • Diseases Causes and Risk Factors
  • Diagnosis
  • Patient Forecasts

Market Trends

  • Market Engineering Measurements
  • Industry Challenges and Strategies
  • Market Drivers

Approved Product Overview

Pipeline Analysis by Mechanism of Action

Revenue Forecasts

Competitive Overview

Market Share Analysis

Related Research
This research service provides an indepth analysis of factors affecting the growth of the U.S. Alzheimer's disease medication market over the period 2006-2016. Following an introduction to the market, which includes segmentation, patient forecasts, and market trends, readers are presented with a detailed examination of therapeutic candidates in Alzheimer's pipeline. Finally, revenue forecasts and market share analyses are presented for existing therapies as well as three new-mechanism drugs with potential to reach the market within the forecast period.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number N731-01-00-00-00
Is Prebook No